Charles Blais

Discovery of 4-Aryl-4<i>H</i>-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-based High-Throughput Screening Assay. 1. Structure−Activity Relationships of the 4-Aryl Group

William Kemnitzer, John Drewe, Songchun Jiang et al. · Journal of Medicinal Chemistry · 2004 · 278 citations

Bradykinin and des-Arg⁹-bradykinin metabolic pathways and kinetics of activation of human plasma

Mélanie Cyr, Yves Lepage, Charles Blais et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2001 · 158 citations

ACE Insertion/Deletion Genotype Affects Bradykinin Metabolism

Nancy J. Brown, Charles Blais, Sanjay Gandhi et al. · Journal of Cardiovascular Pharmacology · 1998 · 119 citations

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema

Charles Blais, Jean‐Lucien Rouleau, Nancy J. Brown et al. · Immunopharmacology · 1999 · 79 citations

Molecular Pharmacology, Vascular Pharmacology, Chronic Kidney Disease +5

Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay

William Kemnitzer, Songchun Jiang, Hong Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations

Medicinal Chemistry, Oxysterol, Biochemistry +11